Technical Analysis for GWPH - GW Pharmaceuticals Plc

Grade Last Price % Change Price Change
grade D 116.1651 -2.48% -2.95
GWPH closed down 0.62 percent on Thursday, October 17, 2019, on 77 percent of normal volume.

Earnings due: Nov 5

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical GWPH trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup -2.48%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.48%
20 DMA Support Bullish -2.48%
Multiple of Ten Bearish Other -2.48%
Outside Day Range Expansion -2.48%
1,2,3 Retracement Bearish Bearish Swing Setup -3.08%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.08%
20 DMA Support Bullish -3.08%
Narrow Range Bar Range Contraction -3.08%
NR7 Range Contraction -3.08%

Older signals for GWPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GW Pharmaceuticals plc, together with its subsidiaries, engages in the research, development, and commercialization of a range of cannabinoid prescription medicines. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in treatment of cancer pain. In addition, the company has two product candidates in Phase II trials in the field of diabetes and inflammation, as well as pre-clinical research programmes evaluating the use of selected cannabinoids for the treatment of glioma, epilepsy, and psychiatric illness. It has a strategic alliance with Otsuka Pharmaceutical Co. Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.
Health Cancer Pharmaceutical Industry Pain Drugs Diabetes Medication Treatment Of Cancer Inflammation Pharmaceutical Industry In China Pharmaceuticals Policy Cannabis Epilepsy Glioma Cannabinoids Neuropathic Pain
Is GWPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 196.0
52 Week Low 90.14
Average Volume 609,195
200-Day Moving Average 155.4651
50-Day Moving Average 134.7998
20-Day Moving Average 118.025
10-Day Moving Average 117.383
Average True Range 6.0348
ADX 30.93
+DI 18.9689
-DI 26.2306
Chandelier Exit (Long, 3 ATRs ) 120.6706
Chandelier Exit (Short, 3 ATRs ) 123.2044
Upper Bollinger Band 128.248
Lower Bollinger Band 107.802
Percent B (%b) 0.55
BandWidth 17.323448
MACD Line -4.8673
MACD Signal Line -6.4135
MACD Histogram 1.5462
Fundamentals Value
Market Cap 3.02 Billion
Num Shares 25.4 Million
EPS -5.64
Price-to-Earnings (P/E) Ratio -21.12
Price-to-Sales 253.36
Price-to-Book 6.23
PEG Ratio 0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 127.54
Resistance 3 (R3) 127.56 124.78 126.13
Resistance 2 (R2) 124.78 122.64 124.77 125.66
Resistance 1 (R1) 121.95 121.31 120.56 121.93 125.20
Pivot Point 119.17 119.17 118.48 119.16 119.17
Support 1 (S1) 116.34 117.03 114.95 116.32 113.04
Support 2 (S2) 113.56 115.70 113.55 112.58
Support 3 (S3) 110.73 113.56 112.11
Support 4 (S4) 110.71